Published in Onkologie on August 01, 1990
Epirubicin. Clinical pharmacology and dose-effect relationship. Drugs (1993) 0.86
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
Single calcium-dependent potassium channels in clonal anterior pituitary cells. Biophys J (1982) 2.26
Randomized clinical trials underestimate the efficacy of antidepressants in less severe depression. Acta Psychiatr Scand (2011) 2.14
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99
Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J Gen Physiol (1992) 1.92
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol (1998) 1.80
SurvNet@RKI--a multistate electronic reporting system for communicable diseases. Euro Surveill (2006) 1.79
Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004. Eur J Clin Microbiol Infect Dis (2009) 1.76
Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates. Arch Pathol Lab Med (2000) 1.74
Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med (1982) 1.71
Fatty liver hepatitis and cirrhosis in obese patients. Am J Med (1979) 1.66
Trends and differential use of assistive technology devices: United States, 1994. Adv Data (1997) 1.64
Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid (2000) 1.59
Modulation of synapse formation by cyclic adenosine monophosphate. Science (1983) 1.56
Perhydrohistrionicotoxin: a potential ligand for the ion conductance modulator of the acetylcholine receptor. Proc Natl Acad Sci U S A (1977) 1.55
The effect of acute severe illness on CD4+ lymphocyte counts in nonimmunocompromised patients. Arch Intern Med (2000) 1.55
Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health (2010) 1.54
Reaction of tetraethylammonium with the open and closed conformations of the acetylcholine receptor ionic channel complex. J Gen Physiol (1979) 1.54
Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience (2002) 1.47
Mycoplasma hominis infection of perihepatic hematomas in a liver transplant recipient. Surgery (1992) 1.47
Hepatitis C infection and membranoproliferative glomerulonephritis. Lancet (1993) 1.47
Kinetic analysis of end plate currents altered by atropine and scopolamine. Mol Pharmacol (1978) 1.45
SARS: retrospective cohort study among German guests of the Hotel 'M', Hong Kong. Euro Surveill (2003) 1.45
Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett (1999) 1.36
Colonoscopic snare polypectomy: analysis of 1485 resections comparing two types of current. Gastrointest Endosc (1992) 1.32
Developing national epidemiologic capacity to meet the challenges of emerging infections in Germany. Emerg Infect Dis (2001) 1.26
Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome. Eur J Clin Microbiol Infect Dis (2003) 1.23
Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients. J Hepatol (1998) 1.20
Mathematical procedures in data recording and processing of pupillary fatigue waves. Vision Res (1998) 1.16
Diagnosis of partial tears of the anterior cruciate ligament of the knee: value of MR imaging. AJR Am J Roentgenol (1995) 1.13
[Evidence for tumor immunity in human malignant melanoma]. Schweiz Med Wochenschr (1970) 1.13
An analysis of the action of atropine and scopolamine on the end-plate current of frog sartorius muscle. J Pharmacol Exp Ther (1976) 1.12
Expression of c-fos and AP-1 activity in senescent human fibroblasts is not sufficient for DNA synthesis. J Cell Biol (1992) 1.12
Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth. Cancer Res (1985) 1.11
Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients. J Clin Microbiol (2011) 1.11
Action potentials and membrane ion channels in clonal anterior pituitary cells. Proc Natl Acad Sci U S A (1983) 1.09
Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc Natl Acad Sci U S A (2000) 1.08
Self-assembly of DNA-streptavidin nanostructures and their use as reagents in immuno-PCR. Nucleic Acids Res (1999) 1.06
Pupillographic assessment of sleepiness in sleep-deprived healthy subjects. Sleep (1998) 1.05
The role of technical assistance in the replication of effective HIV interventions. AIDS Educ Prev (2000) 1.04
Tetraethylammonium blockade of calcium-activated potassium channels in clonal anterior pituitary cells. Pflugers Arch (1986) 1.03
Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. Acta Gastroenterol Belg (2001) 1.03
Nodular regenerative hyperplasia of the liver. A review of 14 cases. Hepatogastroenterology (2001) 1.03
An echovirus 30 outbreak with a high meningitis attack rate among children and household members at four day-care centers. Eur J Epidemiol (1999) 1.01
Assessment of acute and chronic morphine dependence in male and female mice. Pharmacol Biochem Behav (2001) 1.01
Prognostic indices in lupus nephritis. Medicine (Baltimore) (1976) 1.00
The surveillance of communicable diseases in the European Union--a long-term strategy (2008-2013). Euro Surveill (2008) 0.99
Quality indicators for the prevention of type 2 diabetes in Europe--IMAGE. Horm Metab Res (2010) 0.97
Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. Transplantation (1998) 0.97
Sorbitol-fermenting enterohaemorrhagic Escherichia coli O157:H- causes another outbreak of haemolytic uraemic syndrome in children. Epidemiol Infect (2009) 0.96
Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C. Liver (1998) 0.95
Cardiac Na(+)-Ca2+ exchange system in giant membrane patches. Ann N Y Acad Sci (1991) 0.94
Distribution and metabolism of hexadecylphosphocholine in mice. Lipids (1987) 0.94
No Mycobacterium paratuberculosis found in Crohn's disease using polymerase chain reaction. Dig Dis Sci (1996) 0.94
Zoonotic infections in Europe in 2007: a summary of the EFSA-ECDC annual report. Euro Surveill (2009) 0.93
A study of zinc-dependent metalloendopeptidase inhibitors as pharmacological antagonists in botulinum neurotoxin poisoning. Toxicon (1995) 0.93
Trichoderma viride infection in a liver transplant recipient. Mycoses (1993) 0.93
Recurrence of reactive arthritis after a booster dose of tetanus toxoid. Ann Rheum Dis (2002) 0.92
Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma. Respir Med (2005) 0.92
Zoonoses in the European Union: origin, distribution and dynamics - the EFSA-ECDC summary report 2009. Euro Surveill (2011) 0.92
Psychiatric admissions and hospitalization costs in bipolar disorder in Sweden. J Affect Disord (2008) 0.91
Nanostructured dna-protein aggregates consisting of covalent oligonucleotide-streptavidin conjugates. Bioconjug Chem (2001) 0.91
Longitudinal study of meningococcal carrier rates in teenagers. Int J Hyg Environ Health (2007) 0.91
Aminoglutethimide-induced hematologic toxicity: worldwide experience. Cancer Treat Rep (1985) 0.91
Rapid microplate assay for monitoring botulinum neurotoxin B catalytic activity. J Appl Toxicol (1999) 0.91
Efficacy of certain quinolines as pharmacological antagonists in botulinum neurotoxin poisoning. Toxicon (1997) 0.91
Molecular epidemiology of Salmonella enterica serovar Agona: characterization of a diffuse outbreak caused by aniseed-fennel-caraway infusion. Epidemiol Infect (2005) 0.90
alpha-adrenergic antagonists as possible calcium channel inhibitors. Proc Natl Acad Sci U S A (1981) 0.90
Mortality among Pennhurst class members, 1978 to 1989: a brief report. Ment Retard (1998) 0.90
An outbreak of Salmonella München in Germany associated with raw pork meat. J Food Prot (2005) 0.90
Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy. Gut (1992) 0.89
Diagnostic and therapeutic endoscopic retrograde cholangiography after liver transplantation. Gastrointest Endosc (1995) 0.89
Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine. Gastroenterology (1992) 0.89
Funding policies for HIV and AIDS. BMJ (1993) 0.89
Design and implementation of the stavudine parallel-track program. J Infect Dis (1995) 0.89
Radiation effects on the external auditory canal. J Otolaryngol (1985) 0.89
Tetraethylammonium: voltage-dependent action on endplate conductance and inhibition of ligand binding to postsynaptic proteins. Proc Natl Acad Sci U S A (1979) 0.89
Epithelioid hemangioendothelioma of the liver following contact with vinyl chloride. Recurrence after orthotopic liver transplantation. J Hepatol (1989) 0.89
Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. Exp Hematol (1976) 0.89
Survey of medical undergraduate teaching in genitourinary medicine in Britain. Genitourin Med (1986) 0.88
Diagnostic efficacy of push-enteroscopy and long-term follow-up of patients with small bowel angiodysplasias. Dig Dis Sci (1996) 0.88
Whole gut lavage for colonoscopy--a comparison between two solutions. Gastrointest Endosc (1984) 0.88
Ventricular tachycardia as a presenting feature of dermatomyositis. Heart (2002) 0.88
[First evaluation of the surveillance systems of notifiable diseases under the infectious disease control law in Germany]. Gesundheitswesen (2003) 0.88
Pericanalicular hepatocytic and bile ductular microfilaments in cholestasis in man. Am J Pathol (1980) 0.87
Infection control--a European research perspective for the next decade. J Hosp Infect (2010) 0.87
Macroscopic and microscopic gut lesions in seronegative spondyloarthropathies. J Rheumatol (1990) 0.87
Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome. Rheumatology (Oxford) (2007) 0.86
Influenza A outbreak among adolescents in a ski hostel. Eur J Clin Microbiol Infect Dis (1998) 0.86
AIDS: a faltering step. Br Med J (Clin Res Ed) (1987) 0.86
Outbreak of hepatitis A in two federal states of Germany: bakery products as vehicle of infection. Epidemiol Infect (2006) 0.86
Salmonella enteritidis genitourinary tract infection in a homosexual man. J Urol (1982) 0.86
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group. Ann Oncol (1997) 0.86
Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer. Int J Cancer (1984) 0.86
Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. Eur J Cancer (1991) 0.86
ECDC to launch first report on communicable diseases epidemiology in the European Union. Euro Surveill (2007) 0.86
Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition. Blut (1987) 0.86
Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study. J Hepatol (1990) 0.86
High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: preliminary data of a phase-II study. Onkologie (1988) 0.85